Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Cancel

Rare Diseases Perspective

Transition of Rare Disease Patients to Adult Care With new advances in treatments, patients with rare diseases are living much longer. Dr Summar and Ms Nadel talk about how to prepare both patients and practitioners for the transition into adulthood.

Medscape Family Medicine, November 2016

Orphan Disease R & D Has a Home at FDA Dr Rao talks to Dr Whyte about the FDA's orphan products grants program, their mission to promote the development of products, and the patient community's role.

Is Misdiagnosis Inevitable?Although many experts say that doctors have room for improvement in making diagnoses, such factors as rare diseases, atypical presentations, and imperfect screening tests make that less likely.

Medscape Business of Medicine, March 2016

A Focus on Hepatitis C: Cascade of CareIn the first part of this three-part series on hepatitis C, Dr William Balistreri discusses the prevalence of this infection, screening methods, and access and barriers to care.

Medscape Gastroenterology, March 2016

Cardio-Oncology: An Integrative ApproachDr Naveen L Pereira talks to Dr Joerg Herrmann about the importance of bringing cardiology and oncology together and his hopes for the future for the new cardio-oncology clinic.

Mayo Clinic, March 2016

Unilateral Glaucoma?A 44-year-old man presents with blurred vision in one eye that is worse in the morning. What is the cause of his visual complaint?

Medscape Optometry, February 2016

Rare Diseases -- Not Just for Geneticists AnymoreDrs Summar and Saul discuss gaps in education for all clinicians, as pediatric and other rare disease patients live longer, transition to adulthood, and rewrite natural histories of their diseases.

Will PCORnet Save US Clinical Research?Drs Harrington and Hernandez discuss the inefficiencies of the US clinical trial system and their involvement in the National Patient-Centered Clinical Research Network's first trial on aspirin dose.